These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 33610557)

  • 1. Brazilin Removes Toxic Alpha-Synuclein and Seeding Competent Assemblies from Parkinson Brain by Altering Conformational Equilibrium.
    Nahass GR; Sun Y; Xu Y; Batchelor M; Reilly M; Benilova I; Kedia N; Spehar K; Sobott F; Sessions RB; Caughey B; Radford SE; Jat PS; Collinge J; Bieschke J
    J Mol Biol; 2021 Apr; 433(8):166878. PubMed ID: 33610557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brazilin Inhibits α-Synuclein Fibrillogenesis, Disrupts Mature Fibrils, and Protects against Amyloid-Induced Cytotoxicity.
    Liu F; Wang Y; Sang J; Wei W; Zhao W; Chen B; Zhao F; Jia L; Lu F
    J Agric Food Chem; 2019 Oct; 67(42):11769-11777. PubMed ID: 31575115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brazilin inhibits amyloid β-protein fibrillogenesis, remodels amyloid fibrils and reduces amyloid cytotoxicity.
    Du WJ; Guo JJ; Gao MT; Hu SQ; Dong XY; Han YF; Liu FF; Jiang S; Sun Y
    Sci Rep; 2015 Jan; 5():7992. PubMed ID: 25613018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic basis for receptor-mediated pathological α-synuclein fibril cell-to-cell transmission in Parkinson's disease.
    Zhang S; Liu YQ; Jia C; Lim YJ; Feng G; Xu E; Long H; Kimura Y; Tao Y; Zhao C; Wang C; Liu Z; Hu JJ; Ma MR; Liu Z; Jiang L; Li D; Wang R; Dawson VL; Dawson TM; Li YM; Mao X; Liu C
    Proc Natl Acad Sci U S A; 2021 Jun; 118(26):. PubMed ID: 34172566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of Noradrenaline to Native and Intermediate States during the Fibrillation of α-Synuclein Leads to the Formation of Stable and Structured Cytotoxic Species.
    Singh P; Bhat R
    ACS Chem Neurosci; 2019 Jun; 10(6):2741-2755. PubMed ID: 30917654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase separation and other forms of α-Synuclein self-assemblies.
    Poudyal M; Sakunthala A; Mukherjee S; Gadhe L; Maji SK
    Essays Biochem; 2022 Dec; 66(7):987-1000. PubMed ID: 36373662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biasing the native α-synuclein conformational ensemble towards compact states abolishes aggregation and neurotoxicity.
    Carija A; Pinheiro F; Pujols J; Brás IC; Lázaro DF; Santambrogio C; Grandori R; Outeiro TF; Navarro S; Ventura S
    Redox Biol; 2019 Apr; 22():101135. PubMed ID: 30769283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brazilin-7-acetate, a novel potential drug of Parkinson's disease, hinders the formation of α-synuclein fibril, mitigates cytotoxicity, and decreases oxidative stress.
    Cui Z; Guo FY; Li L; Lu F; Jin CH; Wang X; Liu F
    Eur J Med Chem; 2024 Jan; 264():115965. PubMed ID: 38056304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How specific are the conformation-specific α-synuclein antibodies? Characterization and validation of 16 α-synuclein conformation-specific antibodies using well-characterized preparations of α-synuclein monomers, fibrils and oligomers with distinct structures and morphology.
    Kumar ST; Jagannath S; Francois C; Vanderstichele H; Stoops E; Lashuel HA
    Neurobiol Dis; 2020 Dec; 146():105086. PubMed ID: 32971232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology.
    Vaikath NN; Majbour NK; Paleologou KE; Ardah MT; van Dam E; van de Berg WD; Forrest SL; Parkkinen L; Gai WP; Hattori N; Takanashi M; Lee SJ; Mann DM; Imai Y; Halliday GM; Li JY; El-Agnaf OM
    Neurobiol Dis; 2015 Jul; 79():81-99. PubMed ID: 25937088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel conformation-selective alpha-synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson's disease.
    Covell DJ; Robinson JL; Akhtar RS; Grossman M; Weintraub D; Bucklin HM; Pitkin RM; Riddle D; Yousef A; Trojanowski JQ; Lee VM
    Neuropathol Appl Neurobiol; 2017 Dec; 43(7):604-620. PubMed ID: 28386933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The small aromatic compound SynuClean-D inhibits the aggregation and seeded polymerization of multiple α-synuclein strains.
    Peña-Díaz S; Pujols J; Vasili E; Pinheiro F; Santos J; Manglano-Artuñedo Z; Outeiro TF; Ventura S
    J Biol Chem; 2022 May; 298(5):101902. PubMed ID: 35390347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrillar form of α-synuclein-specific scFv antibody inhibits α-synuclein seeds induced aggregation and toxicity.
    Gupta V; Salim S; Hmila I; Vaikath NN; Sudhakaran IP; Ghanem SS; Majbour NK; Abdulla SA; Emara MM; Abdesselem HB; Lukacsovich T; Erskine D; El-Agnaf OMA
    Sci Rep; 2020 May; 10(1):8137. PubMed ID: 32424162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-Synuclein strains cause distinct synucleinopathies after local and systemic administration.
    Peelaerts W; Bousset L; Van der Perren A; Moskalyuk A; Pulizzi R; Giugliano M; Van den Haute C; Melki R; Baekelandt V
    Nature; 2015 Jun; 522(7556):340-4. PubMed ID: 26061766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Innate Host Defense Protein β
    Rani K; Pal A; Gurnani B; Agarwala P; Sasmal DK; Jain N
    J Mol Biol; 2023 Nov; 435(22):168285. PubMed ID: 37741548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human amyloid beta and α-synuclein co-expression in neurons impair behavior and recapitulate features for Lewy body dementia in Caenorhabditis elegans.
    Huang X; Wang C; Chen L; Zhang T; Leung KL; Wong G
    Biochim Biophys Acta Mol Basis Dis; 2021 Oct; 1867(10):166203. PubMed ID: 34146705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a highly neurotoxic α-synuclein species inducing mitochondrial damage and mitophagy in Parkinson's disease.
    Grassi D; Howard S; Zhou M; Diaz-Perez N; Urban NT; Guerrero-Given D; Kamasawa N; Volpicelli-Daley LA; LoGrasso P; Lasmézas CI
    Proc Natl Acad Sci U S A; 2018 Mar; 115(11):E2634-E2643. PubMed ID: 29487216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bifunctional Inhibitor Lentinan Inhibits Fibrillogenesis of Amyloid-β Protein and α-Synuclein and Alleviates Their Cytotoxicity: In Vitro and In Vivo Studies.
    Gao W; Dong Q; Wu X; Wang Y; Li J; Zhang Q; Lu F; Liu F
    ACS Chem Neurosci; 2024 Oct; 15(19):3437-3448. PubMed ID: 39264814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scutellarin inhibits the uninduced and metal-induced aggregation of α-Synuclein and disaggregates preformed fibrils: implications for Parkinson's disease.
    Zaidi FK; Deep S
    Biochem J; 2020 Feb; 477(3):645-670. PubMed ID: 31939603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-aggregation of pro-inflammatory S100A9 with α-synuclein in Parkinson's disease: ex vivo and in vitro studies.
    Horvath I; Iashchishyn IA; Moskalenko RA; Wang C; Wärmländer SKTS; Wallin C; Gräslund A; Kovacs GG; Morozova-Roche LA
    J Neuroinflammation; 2018 Jun; 15(1):172. PubMed ID: 29866153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.